{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:27:46Z","timestamp":1793298466856,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hebei Provincial Administration of Traditional Chinese Medicine","award":["Grant No. 2026136"],"award-info":[{"award-number":["Grant No. 2026136"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16395-3","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:45:52Z","timestamp":1782794752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["NT5E promotes colorectal cancer progression and correlates with PD-L1 expression: evidence from multi-omics analysis, clinical samples, and cellular functional assays"],"prefix":"10.1186","volume":"26","author":[{"given":"Weixing","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weishan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"issue":"2","key":"16395_CR1","doi-asserted-by":"publisher","first-page":"101334","DOI":"10.1016\/j.gendis.2024.101334","volume":"12","author":"R Chang","year":"2025","unstructured":"Chang R, Li G, Jin GN, Zhang B, Ding ZY. Identification of hypermethylated CpG sites mapped to LIFR as specific diagnostic biomarkers of colon cancer. Genes Dis. 2025;12(2):101334.","journal-title":"Genes Dis"},{"issue":"1","key":"16395_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12967-024-05860-x","volume":"23","author":"S An","year":"2025","unstructured":"An S, Cui J, Yang W, Zhang M, Yu H, Lu J, et al. HAS-CIRCpedia-5280 sponges miR-4712-5p inhibited colon cancer autophagyinduced by human beta-defensin-1. J translational Med. 2025;23(1):281.","journal-title":"J translational Med"},{"issue":"1","key":"16395_CR3","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1186\/s12967-024-05927-9","volume":"22","author":"A Di Mauro","year":"2024","unstructured":"Di Mauro A, Santorsola M, Savarese G, Sirica R, Ianniello M, Cossu AM, et al. High tumor mutational burden assessed through next-generation sequencing predicts favorable survival in microsatellite stable metastatic colon cancer patients. J translational Med. 2024;22(1):1107.","journal-title":"J translational Med"},{"issue":"3","key":"16395_CR4","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"16395_CR5","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","volume":"27","author":"E Van Cutsem","year":"2016","unstructured":"Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Annals oncology: official J Eur Soc Med Oncol. 2016;27(8):1386\u2013422.","journal-title":"Annals oncology: official J Eur Soc Med Oncol"},{"issue":"1","key":"16395_CR6","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1186\/s12967-025-07273-w","volume":"23","author":"M Ianniello","year":"2025","unstructured":"Ianniello M, Ottaiano A, Bocchetti M, Ruggiero R, Santorsola M, Sirica R, et al. Tumor mutational burden modulates the prognostic effect of RAS mutations in metastatic colon cancer: mechanistic insights and genotype-phenotype correlations. J translational Med. 2025;23(1):1226.","journal-title":"J translational Med"},{"key":"16395_CR7","doi-asserted-by":"publisher","unstructured":"Benson AB, Venook AP, Adam M, Chang G, Chen YJ, Ciombor KK et al. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Network: JNCCN. 2024;22(2 d). https:\/\/doi.org\/10.6004\/jnccn.2024.0029.","DOI":"10.6004\/jnccn.2024.0029"},{"issue":"1","key":"16395_CR8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41420-025-02405-z","volume":"11","author":"Y Kim","year":"2025","unstructured":"Kim Y, Lee KT, Kim HB, Jung H, Ko JY, Kweon TH, et al. O-GlcNAcylation of NONO regulates paraspeckle component assembly and contributes to colon cancer cell proliferation. Cell death discovery. 2025;11(1):234.","journal-title":"Cell death discovery"},{"issue":"1","key":"16395_CR9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41420-025-02433-9","volume":"11","author":"R Benedetti","year":"2025","unstructured":"Benedetti R, Di Crosta M, Gilardini Montani MS, D\u2019Orazi G, Cirone M. Mutant p53 upregulates HDAC6 to resist ER stress and facilitates Ku70 deacetylation, which prevents its degradation and mitigates DNA damage in colon cancer cells. Cell death discovery. 2025;11(1):162.","journal-title":"Cell death discovery"},{"issue":"1","key":"16395_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41420-025-02416-w","volume":"11","author":"H Kim","year":"2025","unstructured":"Kim H, Kim H, Jang E, Eom YW, Yoon G, Choi KS, et al. Dual role of p21 in regulating apoptosis and mitotic integrity in response to doxorubicin in colon cancer cells. Cell death discovery. 2025;11(1):133.","journal-title":"Cell death discovery"},{"issue":"1","key":"16395_CR11","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1186\/s12967-025-07226-3","volume":"23","author":"K Gao","year":"2025","unstructured":"Gao K, Zhang J, Liu C, Yang Y, Wang J, Zhang J, et al. Fusobacterium nucleatum enhances oxaliplatin resistance in colon cancer by increasing PVT1 expression. J translational Med. 2025;23(1):1112.","journal-title":"J translational Med"},{"issue":"1","key":"16395_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41420-024-02136-7","volume":"10","author":"Y Sun","year":"2024","unstructured":"Sun Y, Liu D, Zhang X, Su P, Li X, Li Z, et al. Regulation of Hippo\/YAP axis in colon cancer progression by the deubiquitinase JOSD1. Cell death discovery. 2024;10(1):365.","journal-title":"Cell death discovery"},{"issue":"1","key":"16395_CR13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12967-025-06075-4","volume":"23","author":"Y Lee","year":"2025","unstructured":"Lee Y, Ko D, Yoon J, Kim S. TMEM52B-derived peptides inhibit generation of soluble E-cadherin and EGFR activity to suppress colon cancer growth and early metastasis. J translational Med. 2025;23(1):146.","journal-title":"J translational Med"},{"key":"16395_CR14","first-page":"409","volume-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Volume 357. New York, NY: Science; 2017. pp. 409\u201313. 6349."},{"issue":"1","key":"16395_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13045-022-01294-4","volume":"15","author":"J Weng","year":"2022","unstructured":"Weng J, Li S, Zhu Z, Liu Q, Zhang R, Yang Y, et al. Exploring immunotherapy in colorectal cancer. J Hematol Oncol. 2022;15(1):95.","journal-title":"J Hematol Oncol"},{"key":"16395_CR16","doi-asserted-by":"publisher","unstructured":"Sun Y, Li L, Cai L, Yang J, Qian J, Wang F et al. Prognostic value and clinical significance of tumoral PD-L1 and stromal \u03b1-SMA expression in diffuse pleural mesothelioma. Neoplasma; 2026. https:\/\/doi.org\/10.4149\/neo_2026_251018N437.","DOI":"10.4149\/neo_2026_251018N437"},{"issue":"1","key":"16395_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12885-017-3291-8","volume":"17","author":"M Xie","year":"2017","unstructured":"Xie M, Qin H, Luo Q, Huang Q, He X, Yang Z, et al. MicroRNA-30a regulates cell proliferation and tumor growth of colorectal cancer by targeting CD73. BMC Cancer. 2017;17(1):305.","journal-title":"BMC Cancer"},{"issue":"9","key":"16395_CR18","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1517\/14728222.2014.925883","volume":"18","author":"L Antonioli","year":"2014","unstructured":"Antonioli L, Hask\u00f3 G, Fornai M, Colucci R, Blandizzi C. Adenosine pathway and cancer: where do we go from here? Expert Opin Ther Targets. 2014;18(9):973\u20137.","journal-title":"Expert Opin Ther Targets"},{"issue":"5","key":"16395_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"issue":"3","key":"16395_CR20","first-page":"100625","volume":"5","author":"B Gy\u0151rffy","year":"2024","unstructured":"Gy\u0151rffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innov (Cambridge (Mass)). 2024;5(3):100625.","journal-title":"Innov (Cambridge (Mass))"},{"key":"16395_CR21","first-page":"1260419","volume-title":"Proteomics. Tissue-based map of the human proteome","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Volume 347. New York, NY: Science; 2015. p. 1260419. 6220."},{"key":"16395_CR22","doi-asserted-by":"publisher","first-page":"460654","DOI":"10.1155\/2014\/460654","volume":"2014","author":"ZW Gao","year":"2014","unstructured":"Gao ZW, Dong K, Zhang HZ. The roles of CD73 in cancer. Biomed Res Int. 2014;2014:460654.","journal-title":"Biomed Res Int"},{"issue":"19","key":"16395_CR23","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.2174\/0929867325666180117101114","volume":"25","author":"J Yang","year":"2018","unstructured":"Yang J, Liao X, Yu J, Zhou P. Role of CD73 in Disease: Promising Prognostic Indicator and Therapeutic Target. Curr Med Chem. 2018;25(19):2260\u201371.","journal-title":"Curr Med Chem"},{"issue":"7","key":"16395_CR24","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.32604\/or.2025.061637","volume":"33","author":"C Cheng","year":"2025","unstructured":"Cheng C, Shi C, Wu S, Wu W, Li J, Gao S, et al. Tumor-expressing PD-L1 regulates NT5E expression through MAPK\/ERK pathway in triple-negative breast cancer. Oncol Res. 2025;33(7):1633\u201348.","journal-title":"Oncol Res"},{"issue":"2","key":"16395_CR25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/jso.23056","volume":"106","author":"XR Wu","year":"2012","unstructured":"Wu XR, He XS, Chen YF, Yuan RX, Zeng Y, Lian L, et al. High expression of CD73 as a poor prognostic biomarker in human colorectal cancer. J Surg Oncol. 2012;106(2):130\u20137.","journal-title":"J Surg Oncol"},{"issue":"7","key":"16395_CR26","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/jso.23159","volume":"106","author":"N Liu","year":"2012","unstructured":"Liu N, Fang XD, Vadis Q. CD73 as a novel prognostic biomarker for human colorectal cancer. J Surg Oncol. 2012;106(7):918\u20139. author reply 20.","journal-title":"J Surg Oncol"},{"issue":"8","key":"16395_CR27","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/s41416-024-02826-0","volume":"131","author":"S Chowdhury","year":"2024","unstructured":"Chowdhury S, Xiu J, Ribeiro JR, Nicolaides T, Zhang J, Korn WM, et al. Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumors. Br J Cancer. 2024;131(8):1328\u201339.","journal-title":"Br J Cancer"},{"issue":"11","key":"16395_CR28","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, Dienstmann R, Wang X, de Reyni\u00e8s A, Schlicker A, Soneson C, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21(11):1350\u20136.","journal-title":"Nat Med"},{"issue":"5","key":"16395_CR29","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/ags3.12362","volume":"4","author":"H Sawayama","year":"2020","unstructured":"Sawayama H, Miyamoto Y, Ogawa K, Yoshida N, Baba H. Investigation of colorectal cancer in accordance with consensus molecular subtype classification. Annals gastroenterological Surg. 2020;4(5):528\u201339.","journal-title":"Annals gastroenterological Surg"},{"issue":"4","key":"16395_CR30","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/jnci\/djab106","volume":"114","author":"S Ten Hoorn","year":"2022","unstructured":"Ten Hoorn S, de Back TR, Sommeijer DW, Vermeulen L. Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis. J Natl Cancer Inst. 2022;114(4):503\u201316.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"16395_CR31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12885-017-3128-5","volume":"17","author":"ZW Gao","year":"2017","unstructured":"Gao ZW, Wang HP, Lin F, Wang X, Long M, Zhang HZ, et al. CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity. BMC Cancer. 2017;17(1):135.","journal-title":"BMC Cancer"},{"issue":"6","key":"16395_CR32","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1172\/JCI45559","volume":"121","author":"L Wang","year":"2011","unstructured":"Wang L, Fan J, Thompson LF, Zhang Y, Shin T, Curiel TJ, et al. CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice. J Clin Invest. 2011;121(6):2371\u201382.","journal-title":"J Clin Invest"},{"issue":"1","key":"16395_CR33","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1186\/s12885-019-6127-x","volume":"19","author":"M Aoki","year":"2019","unstructured":"Aoki M, Koga K, Miyazaki M, Hamasaki M, Koshikawa N, Oyama M, et al. CD73 complexes with emmprin to regulate MMP-2 production from co-cultured sarcoma cells and fibroblasts. BMC Cancer. 2019;19(1):912.","journal-title":"BMC Cancer"},{"issue":"1","key":"16395_CR34","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41420-025-02503-y","volume":"11","author":"DM Xu","year":"2025","unstructured":"Xu DM, Chen LX, Xue T, Zhuang XY, Wei LC, Han H, et al. Decoding the impact of MMP1\u2009+\u2009malignant subsets on tumor-immune interactions: insights from single-cell and spatial transcriptomics. Cell death discovery. 2025;11(1):244.","journal-title":"Cell death discovery"},{"issue":"1","key":"16395_CR35","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s12967-025-06596-y","volume":"23","author":"Q Wang","year":"2025","unstructured":"Wang Q, Feng W, Tan Y, Qiao J, Liu H, Liu Q, et al. Antiphospholipid antibodies inhibit the migration and invasion of trophoblast cells by suppressing the JNK\/C-Jun\/MMP1 signaling pathway. J translational Med. 2025;23(1):581.","journal-title":"J translational Med"},{"issue":"5","key":"16395_CR36","doi-asserted-by":"publisher","first-page":"101529","DOI":"10.1016\/j.gendis.2025.101529","volume":"12","author":"S Tian","year":"2025","unstructured":"Tian S, Chen X, Li J. Zinc finger transcription factor ZNF24 inhibits colorectal cancer growth and metastasis by suppressing MMP2 transcription. Genes Dis. 2025;12(5):101529.","journal-title":"Genes Dis"},{"issue":"1","key":"16395_CR37","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41420-024-01962-z","volume":"10","author":"P Xing","year":"2024","unstructured":"Xing P, Liu H, Xiao W, Zhang G, Zhang C, Liao Z, et al. The fusion gene LRP1-SNRNP25 drives invasion and migration by activating the pJNK\/37LRP\/MMP2 signaling pathway in osteosarcoma. Cell death discovery. 2024;10(1):198.","journal-title":"Cell death discovery"},{"key":"16395_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.canlet.2021.01.030","volume":"505","author":"KC Kurnit","year":"2021","unstructured":"Kurnit KC, Draisey A, Kazen RC, Chung C, Phan LH, Harvey JB, et al. Loss of CD73 shifts transforming growth factor-\u03b21 (TGF-\u03b21) from tumor suppressor to promoter in endometrial cancer. Cancer Lett. 2021;505:75\u201386.","journal-title":"Cancer Lett"},{"issue":"1","key":"16395_CR39","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41420-025-02536-3","volume":"11","author":"Z Wang","year":"2025","unstructured":"Wang Z, Sun H, Zhu S, Wang F, Li Q, Zhou J. RGS3 acts as a tumor promoter by facilitating the regulation of the TGF-\u03b2 signaling pathway and promoting EMT in ovarian cancer. Cell death discovery. 2025;11(1):262.","journal-title":"Cell death discovery"},{"issue":"1","key":"16395_CR40","doi-asserted-by":"publisher","first-page":"101771","DOI":"10.1016\/j.gendis.2025.101771","volume":"13","author":"C Liu","year":"2026","unstructured":"Liu C, Wang S, Zhang X, Han Y, Tan M, Fan J, et al. The biomechanical signature of tumor invasion. Genes Dis. 2026;13(1):101771.","journal-title":"Genes Dis"},{"issue":"1","key":"16395_CR41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/imr.12528","volume":"276","author":"B Allard","year":"2017","unstructured":"Allard B, Longhi MS, Robson SC, Stagg J. The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets. Immunol Rev. 2017;276(1):121\u201344.","journal-title":"Immunol Rev"},{"issue":"35","key":"16395_CR42","doi-asserted-by":"publisher","first-page":"13132","DOI":"10.1073\/pnas.0605251103","volume":"103","author":"A Ohta","year":"2006","unstructured":"Ohta A, Gorelik E, Prasad SJ, Ronchese F, Lukashev D, Wong MK, et al. A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci USA. 2006;103(35):13132\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"16395_CR43","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.ymthe.2021.08.011","volume":"30","author":"X Lin","year":"2022","unstructured":"Lin X, Zhuang S, Chen X, Du J, Zhong L, Ding J, et al. lncRNA ITGB8-AS1 functions as a ceRNA to promote colorectal cancer growth and migration through integrin-mediated focal adhesion signaling. Mol therapy: J Am Soc Gene Therapy. 2022;30(2):688\u2013702.","journal-title":"Mol therapy: J Am Soc Gene Therapy"},{"issue":"1","key":"16395_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrc.2017.96","volume":"18","author":"B Ogretmen","year":"2018","unstructured":"Ogretmen B. Sphingolipid metabolism in cancer signalling and therapy. Nat Rev Cancer. 2018;18(1):33\u201350.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"16395_CR45","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s41580-022-00508-4","volume":"23","author":"P Lappalainen","year":"2022","unstructured":"Lappalainen P, Kotila T, J\u00e9gou A, Romet-Lemonne G. Biochemical and mechanical regulation of actin dynamics. Nat Rev Mol Cell Biol. 2022;23(12):836\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"16395_CR46","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4161\/cam.28024","volume":"8","author":"P Najm","year":"2014","unstructured":"Najm P, El-Sibai M. Palladin regulation of the actin structures needed for cancer invasion. Cell Adhes Migr. 2014;8(1):29\u201335.","journal-title":"Cell Adhes Migr"},{"issue":"1","key":"16395_CR47","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13046-023-02644-x","volume":"42","author":"Y Dong","year":"2023","unstructured":"Dong Y, Jin Q, Sun M, Qi D, Qu H, Wang X, et al. CLDN6 inhibits breast cancer metastasis through WIP-dependent actin cytoskeleton-mediated autophagy. J experimental Clin cancer research: CR. 2023;42(1):68.","journal-title":"J experimental Clin cancer research: CR"},{"issue":"1","key":"16395_CR48","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7150\/ijbs.87440","volume":"20","author":"W Lian","year":"2024","unstructured":"Lian W, Jiang D, Lin W, Jiang M, Zhang Y, Wang H, et al. Dual role of CD73 as a signaling molecule and adenosine-generating enzyme in colorectal cancer progression and immune evasion. Int J Biol Sci. 2024;20(1):137\u201351.","journal-title":"Int J Biol Sci"},{"key":"16395_CR49","doi-asserted-by":"publisher","unstructured":"Hao Z, Zhang M, Du Y, Liu J, Zeng G, Li H et al. Invadopodia in cancer metastasis: dynamics, regulation, and targeted therapies. Journal of translational medicine. 2025;23(1):548. HCT1116 cell lineimplications for colorectal cancer liver metastasis. Journal of translational medicine. 2025;23(1):340. https:\/\/doi.org\/10.1186\/s12967-025-06526-y.","DOI":"10.1186\/s12967-025-06526-y"},{"issue":"4","key":"16395_CR50","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jcmgh.2022.07.005","volume":"14","author":"JY Noh","year":"2022","unstructured":"Noh JY, Lee IP, Han NR, Kim M, Min YK, Lee SY, et al. Additive Effect of CD73 Inhibitor in Colorectal Cancer Treatment With CDK4\/6 Inhibitor Through Regulation of PD-L1. Cell Mol Gastroenterol Hepatol. 2022;14(4):769\u201388.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"16395_CR51","doi-asserted-by":"publisher","first-page":"116174","DOI":"10.1016\/j.intimp.2026.116174","volume":"172","author":"H Aria","year":"2026","unstructured":"Aria H, Bakherad H, Mehdipour AR, Azizi M, Rezaei M. Design, engineering, and functional evaluation of nanobody-based anti-CD73 for immunogenic cell death induction in chemoresistant colorectal Cancer cell line. Int Immunopharmacol. 2026;172:116174.","journal-title":"Int Immunopharmacol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16395-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16395-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16395-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:18:18Z","timestamp":1789694298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16395-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16395"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16395-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9339416\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki (2013 revision) and was approved by the Ethics Committee of Qinhuangdao First Hospital (Approval No.: 2025\u00a0K-255-01). Informed consent was obtained from all patients.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1115"}}